- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Adempas, as a treatment drug for pulmonary arterial hypertension, has side effects that involve multiple systems and require targeted relief me...
Adempas, as a targeted therapy for pulmonary arterial hypertension, has clear indications and strict adherence to medication precautions. The f...
Micatrio, as a composite preparation, should be used and administered according to age and weight stratification. Special attention should be p...
Micatrio has shown significant clinical efficacy in the treatment of cystic fibrosis, and its discontinuation should follow standardized proced...
Vornoxant, as a novel orexin receptor antagonist, mainly involves central nervous system and digestive system reactions in its side effects, requ...
Vornoxant, as a novel orexin receptor antagonist, is mainly used to treat chronic insomnia in adults. Its use requires special attention to cen...
Olmetec, as an angiotensin II receptor antagonist, is mainly used for the treatment of hypertension. Its usage needs to be adjusted according t...
Olmetec, as a long-acting antihypertensive drug, has significant therapeutic effects and good safety. However, caution should be exercised when...
Aprepitant, as a neurokinin-1 receptor antagonist, is mainly used for the prevention of chemotherapy-induced nausea and vomiting. Its side effe...
Aprepitant, as a neurokinin-1 receptor antagonist, is mainly indicated for the prevention and treatment of chemotherapy-induced nausea and vomi...
